Systemic Autoimmune Diseases

Immunology
0
Pipeline Programs
4
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Design Therapeutics
1 program
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:N/A
Sanofi
SanofiPARIS, France
1 program
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:N/A
Bayer
BayerLEVERKUSEN, Germany
1 program
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:N/A
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:N/A1 trial
Active Trials
NCT02890121Completed2,006Est. Oct 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Eli Lilly and CompanyMolecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:

Clinical Trials (1)

Total enrollment: 2,006 patients across 1 trials

NCT02890121Eli Lilly and CompanyMolecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:

Start: Dec 2014Est. completion: Oct 20172,006 patients
N/ACompleted

Related Jobs in Immunology

Regulatory Affairs Manager(Immunology), Korea

AbbVie
Seoul, Seoul
6h ago

Regional Sales Trainer - Rheumatology (Mid Atlantic/Central)

AbbVie
Remote
7h ago

Product Specialist - Immunology

Johnson & Johnson
Kibbutz Shefayim, Center District, Israel
20h ago

Senior Area Business Specialist, Immunology - Detroit, MI - Johnson & Johnson Innovative Medicine

Johnson & Johnson
Detroit, Michigan, United States
20h ago

Senior Medical Science Liaison, Dermatology - Indianapolis

Johnson & Johnson
Indianapolis, Indiana, United States
20h ago
$137K - $236K/yr

Field Reimbursement Manager - Rheumatology - Seattle, WA (North)

Johnson & Johnson
Seattle, Washington, United States of America
20h ago
$100K - $175K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

Related Indications

Rheumatoid Arthritis(475)Psoriasis(206)Ulcerative Colitis(151)Atopic Dermatitis(144)Crohn's Disease(140)Systemic Lupus Erythematosus(85)Arthritis, Rheumatoid(61)Plaque Psoriasis(53)Crohn Disease(49)Ankylosing Spondylitis(33)